These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 24320)

  • 1. "False positive" acidified serum test in a preleukemic dyserythropoiesis.
    Hauptmann G; Sondag D; Lang JM; Oberling F
    Acta Haematol; 1978; 59(2):73-9. PubMed ID: 24320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear bridging of erythroblasts in acquired dyserythropoiesis: an early and transient preleukemic marker.
    Bethlenfalvay NC; Phaure TA; Phyliky RL; Bowman RP
    Am J Hematol; 1986 Mar; 21(3):315-22. PubMed ID: 3946411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Logue GL; Adams J; Crookston JH
    J Clin Invest; 1974 Jan; 53(1):31-43. PubMed ID: 4855546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous assessment of the complement-sensitive cells of red cells and reticulocytes in paroxysmal nocturnal hemoglobinuria by complement lysis sensitivity test].
    Shichishima T; Terasawa T; Matsuda M; Uchida T; Kariyone S
    Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1318-24. PubMed ID: 3825451
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by acid-activated serum.
    Hänsch G; Hammer C; Jiji R; Rother U; Shin M
    Immunobiology; 1983 Mar; 164(2):118-26. PubMed ID: 6852860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dyserythropoietic anemia].
    Fereberger W
    Acta Med Austriaca Suppl; 1979; 6():281-6. PubMed ID: 299214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant congenital dyserythropoietic anemia with negative acidified serum tests and features of thalassemia in a Kurdish family.
    Eldor A; Matzner Y; Kahane I; Levene C; Polliack A
    Isr J Med Sci; 1978 Nov; 14(11):1138-43. PubMed ID: 750540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.
    Moore JG; Humphries RK; Frank MM; Young N
    Exp Hematol; 1986 Mar; 14(3):222-9. PubMed ID: 3512279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of paroxysmal nocturnal hemoglobinuria erythrocytes: increased lysis and lipid peroxide formation by hydrogen peroxide.
    Mengel CE; Kann HE; Meriwether WD
    J Clin Invest; 1967 Nov; 46(11):1715-23. PubMed ID: 6061745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation and quantification of complement-sensitive red cells in PNH and aplastic anemia-PNH syndrome].
    Shichishima T; Terasawa T; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Mar; 30(3):297-302. PubMed ID: 2769953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refractory and sideroblastic anemias].
    Fereberger W
    Wien Med Wochenschr; 1984 Feb; 134(3-4):85-9. PubMed ID: 6711007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual type of congenital dyserythropoietic anemia with thalassemia features.
    Berrebi A; Nir E
    Isr J Med Sci; 1978 Nov; 14(11):1135-7. PubMed ID: 750539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sideroblastic anemias].
    Bernát Sándor I; Hartai M; Kormányos E; Bernát I
    Orv Hetil; 1991 Dec; 132(48):2669-72. PubMed ID: 1758693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interrelationship between preleukemic dyserythropoiesis and erythromyelosis].
    Degtiareva MM
    Ter Arkh; 1980; 52(9):23-7. PubMed ID: 7434228
    [No Abstract]   [Full Text] [Related]  

  • 19. [The preleukemic syndrome. Dysplasia hemopoietica].
    Majolino I; Panizza P; Nalli G; Trpin L; Barosi G; Ascari E
    Recenti Prog Med; 1978 Apr; 64(4):404-45. PubMed ID: 356143
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.
    Rosse WF; Dacie JV
    J Clin Invest; 1966 May; 45(5):736-48. PubMed ID: 5935361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.